Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-03-15
1995-03-07
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 514 11, 530300, 530317, 530321, 530324, A61K 3800, C07K 500, C07K 700, C07K 1400
Patent
active
053958233
ABSTRACT:
Agonists of NPY which are derivatives of naturally occurring NPY. The agonism is confirmed using conventional competitive binding and biochemical assays and the use of these derivatives in a variety of conditions in which neuropeptide Y is implicated is also described.
REFERENCES:
patent: 4355025 (1982-11-01), Lazarus
patent: 4701441 (1987-11-01), Kalra
patent: 4808701 (1989-02-01), Danho et al.
patent: 4839343 (1989-06-01), Waeber et al.
patent: 4891357 (1990-01-01), Kalra
Beck et al., FEBS Letters, vol. 244, No. 1, Feb. 1989, pp. 119-122.
Tatemoto, K., "Neuropeptide Y: Complete amino acid sequence of the brain peptide," Proc. Natl. Acad. Sci. USA, Biochemistry, vol. 79, pp. 5485-5489, 1982.
Beck, A., et al., "Highly potent and small neuropeptide Y agonist obtained by linking NPY 1-4 via spacer to .alpha.-helical NPY 25-36", 6096 FEBS Letters, 244, No. 1, 1989.
Krstenansky, J. L., et al., "Centrally truncated and stabilized porcine neuropeptide Y analogs: Design, synthesis and mouse brain receptor binding," Proc. Natl. Acad. Sci USA, Biochemistry, vol. 86, pp. 4377-4381, 1989.
Boublik, J., et al., "Neuropeptide Y and neuropeptide Y.sub.18-36", Int. J. Peptide Protein Res. 33, 11-15 (1989).
Boublik, J. H., "Synthesis and Hypertensive Activity of Neuropeptide Y Fragments and Analogues with Modified N-or C-Termini or D-Sustitutions", J. Med. Chem. 32(3), 597-601(1989).
Cox, et al., Peptides vol. 12:323-327 (1991).
Dockray, G. J., Neuropeptide Y: In Search of a Function, Neurochem. Int. 8(1), 9-11 (1986).
Maccarrone, C. and Jarrott, B., Neuropeptide Y: A Punitive Neurotransmitter, Neurochem. Int. 8(1), 13-22 (1986).
J. M. Danger, et al., Life Sciences, vol. 40, No. 19 pp. 1875-1880, (1987).
Martel, et al., Peptides 7, pp. 55-60 (1986).
Rioux, et al., Peptides 7, pp. 27-31 (1986).
J. M. Allen, et al., Neurochem. Int. vol. 8, No. 1, pp. 1-8 (1986).
"Peptide Neuroregulation of Vascular Tone by the Sympathetic nervous System", Elsevier Science Publishers B. V., Amsterdam pp. 383-384 (1986).
J. M. Lundberg, et al., European Journal of Pharmacology, 145, pp. 21-29, (1988).
J. G. Clarke, et al., The Lancet, 1057-1059, (1987).
A. Balasubramaniam, et al. Int. J. Peptide protein Res. 29, 78-83 (1987).
T. Mochizuki et al., Peptide Chemicstry 20: 59-64 (1982).
J. L. Krstenansky, et al., Neuropeptides 10, 77-85 (1987).
Collier Kenneth J.
Davenport A. M.
Merrell Dow Pharmaceuticals Inc.
Warden Jill
LandOfFree
Neuropeptide Y agonists and partial agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuropeptide Y agonists and partial agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuropeptide Y agonists and partial agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1406053